Related Experiment Videos
Strand breaks are repaired efficiently in human ribosomal genes
L K Fritz1, C Suquet, M J Smerdon
1Department of Biochemistry and Biophysics, Washington State University, Pullman, Washington 99164-4660, USA.
The Journal of Biological Chemistry
|May 31, 1996
Summary
Human fibroblasts efficiently repair DNA strand breaks caused by bleomycin in ribosomal DNA (rDNA) and dihydrofolate reductase (DHFR) genes. Ribosomal DNA lesions are repaired rapidly by base excision repair, unlike UV photodimers.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Anti-cancer drugs like bleomycin induce DNA strand breaks.
- DNA repair mechanisms are crucial for cellular integrity and preventing mutations.
- Ribosomal DNA (rDNA) and dihydrofolate reductase (DHFR) genes are essential for cellular function.
Purpose of the Study:
- To investigate the repair of bleomycin-induced DNA strand breaks in Pol I and Pol II transcribed genes.
- To compare the repair efficiency of single-strand breaks (SSBs) and UV photodimers in human rDNA.
- To determine if DNA repair pathways exhibit strand bias in transcribed genes.
Main Methods:
- Utilized permeabilized human fibroblasts to study DNA repair.
- Induced DNA strand breaks using the anti-cancer drug bleomycin.
- Examined repair in specific fragments of rDNA (Pol I) and DHFR (Pol II) genes.
- Assessed repair of SSBs and UV photodimers in both transcribed and non-transcribed strands.
Main Results:
- Bleomycin induced primarily SSBs (>80%) with no strand bias in rDNA.
- Rapid repair of SSBs was observed in both rDNA (80% in 60 min) and DHFR (60% in 60 min) genes.
- Little to no repair of UV photodimers occurred in human rDNA, irrespective of cell confluency or growth state.
Conclusions:
- Human ribosomal genes show efficient and rapid repair of SSBs via base excision repair.
- DNA lesions in ribosomal genes appear more accessible to base excision repair than nucleotide excision repair.
- Findings suggest differential accessibility of DNA lesions to repair enzymes based on gene type and lesion type.